Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Use of cilostazol, clopidogrel and aspirin results in a significant reduction of thrombotic complications in the prevention of heart attacks

Use of cilostazol, clopidogrel and aspirin results in a significant reduction of thrombotic complications in the prevention of heart attacks

Studies find Aspirin resistance in up to 27% of Aspirin users

Studies find Aspirin resistance in up to 27% of Aspirin users

St. John's wort increases effectiveness of Plavix

St. John's wort increases effectiveness of Plavix

Heart patients with gastrointestinal complications should use low doses of aspirin combined with drugs that treat stomach ulcers

Heart patients with gastrointestinal complications should use low doses of aspirin combined with drugs that treat stomach ulcers

Clopidogrel (Plavix®) responses appear normal in largest data set

Clopidogrel (Plavix®) responses appear normal in largest data set

Angioplasty may replace bypass for more patients who are also receiving a new heart valve

Angioplasty may replace bypass for more patients who are also receiving a new heart valve

Guidelines introduce novel therapies for the prevention and treatment of thrombosis

Guidelines introduce novel therapies for the prevention and treatment of thrombosis

No benefit from early PCI/CABG in high risk unstable angina patients

No benefit from early PCI/CABG in high risk unstable angina patients

Aspirin surgery on neck arteries can prevent complications

Aspirin surgery on neck arteries can prevent complications